Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Rouen
• Treatments: Rituximab

Criteria

Inclusion Criteria:

• failure to at least one TNF-blocking agent

Exclusion Criteria:

• pregnant or childbearing woman

• Rituximab contraindication

• woman unable to use contraceptive means